Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel hybrids of thiazolidinedione-1,3,4-oxadiazole derivatives: synthesis, molecular docking, MD simulations, ADMET study, in vitro, and in vivo anti-diabetic assessment
Mahendra Gowdru Srinivasa, Jagdish Gopal Paithankar, Sumit Birangal, et al.
RSC Advances (2023) Vol. 13, Iss. 3, pp. 1567-1579
Open Access | Times Cited: 18

Showing 18 citing articles:

Integrated computational modeling and in-silico validation of flavonoids-Alliuocide G and Alliuocide A as therapeutic agents for their multi-target potential: Combination of molecular docking, MM-GBSA, ADMET and DFT analysis
Nusrat Shafiq, Misha Arshad, Awais Ali, et al.
South African Journal of Botany (2024) Vol. 169, pp. 276-300
Closed Access | Times Cited: 12
New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study
Marwa I. Serag, Samar S. Tawfik, Sahar Badr, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Design, synthesis, and antidiabetic evaluation of thiazolidinedione derivatives as potent PPAR-γ Agonists: Insights from molecular docking, MD simulations and invitro studies
Mahendra Gowdru Srinivasa, Karthik G. Pujar, P. Prabitha
Journal of Molecular Structure (2025), pp. 141324-141324
Closed Access
Key molecular scaffolds in the development of clinically viable α-amylase inhibitors
Rahul Pratap Singh, Jayant Sindhu, Devender Singh, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 3, pp. 347-362
Closed Access
Evaluation of In Silico and In Vitro Antidiabetic Properties of 4-(Hydroxysubstituted Arylidene)-2-Phenyloxazol-5(4H)-one Derivatives
R. Jayasinghe, Nawanjana T. Padukkage Dona, Visal C. Lorensu Hewage, et al.
ACS Omega (2025)
Open Access
In Silico Studies of (Z)-3-(2-Chloro-4-Nitrophenyl)-5-(4-Nitrobenzylidene)-2-Thioxothiazolidin-4-One Derivatives as PPAR-γ Agonist: Design, Molecular Docking, MM-GBSA Assay, Toxicity Predictions, DFT Calculations and MD Simulation Studies
Mahendra Gowdru Srinivasa, S. R. NAIK, D. Udaya Kumar, et al.
Journal of Computational Biophysics and Chemistry (2023) Vol. 23, Iss. 01, pp. 117-136
Closed Access | Times Cited: 7
1,3,4-Oxadiazole Scaffold in Antidiabetic Drug Discovery: An Overview
Ojasvi Gupta, Gita Chawla, Tathagata Pradhan
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 20, pp. 1800-1821
Closed Access | Times Cited: 2
Evaluation of antidiabetic and antioxidant effects of Polygonum cognatum Meisn. and phytochemical analysis of effective extracts
Sefa Gözcü, Rüstem Anıl Uğan, Hilal Özbek, et al.
Biomedical Chromatography (2023) Vol. 38, Iss. 3
Closed Access | Times Cited: 6
α‐Amylase Inhibitors Based on Thiazolidinone Skeleton: A Promising Approach in Diabetes Management
Rahul Singh, Jayant Sindhu, Parvin Kumar, et al.
ChemistrySelect (2023) Vol. 8, Iss. 48
Closed Access | Times Cited: 4
Molecular Docking, Synthesis, and Characterization of Furanyl‐Pyrazolyl Acetamide and 2,4‐Thiazolidinyl‐Furan‐3‐Carboxamide Derivatives as Neuroinflammatory Protective Agents
Sowjanya Mudimela, Vijayasree V. Giridharan, S. Janardhan
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 1
Medicinal Perspective of 2,4‐Thiazolidinediones Derivatives: An Insight into Recent Advancements
Sneha Gupta, Sumeet Jha, Supriya Rani, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Recent chemistry and applications of 1,3,4-oxadiazoles
Yaroslav K. Gorbunov, Леонид Л. Ферштат
Advances in heterocyclic chemistry (2023), pp. 1-26
Closed Access | Times Cited: 3
Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review
Pushkar Kumar Ray, Km Shabana, Salahuddin Salahuddin, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 10, pp. 885-928
Closed Access
Antioxidant and Antitumor Potential of Some Benzoxazines Against MCF‐7 Cell Lines Using InVitro and InSilico Approaches
Hanane Mouada, Kamel Hachama, Imran Zafar, et al.
ChemistrySelect (2024) Vol. 9, Iss. 33
Closed Access
Synthesis, Aromatase Inhibition, Cytotoxicity and Molecular Docking Studies of New Fluorinated and Non‐fluorinated Thiourea Derivatives of Desloratadine
Muhammad Sajid, H.L. Siddiqui, Muhammad Atif, et al.
Chemistry & Biodiversity (2024)
Open Access
Exploring Thiazolidinedione-Naphthalene Analogues as Potential Antidiabetic Agents: Design, Synthesis, Molecular Docking and In-vitro Evaluation
Sharfuddin Mohd, Vikas Sharma, Vancha Harish, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Exploring 1,3,4-Oxadiazole Derivatives as Potent α-Amylase Inhibitors: Design, Synthesis, and Biological Evaluation
Sulochana R. Rathod and Ashok M.Chavan, Sonali A. Waghmare, Shraddha S. Bodke, et al.
Eurasian Journal of Chemistry (2023) Vol. 112, Iss. 4, pp. 30-43
Open Access


Eurasian Journal of Chemistry (2023) Vol. 112, Iss. 4
Closed Access
Page 1

Scroll to top